PRESS RELEASE published on 01/17/2024 at 08:00, 1 year 2 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 04/03/2025 at 11:00, 1 hour 25 minutes ago Focus Graphite Advanced Materials Initiates Validation Testing of Lac Knife Anode Materials with Leading Battery Innovator C4V
Published on 04/03/2025 at 05:10, 7 hours 15 minutes ago Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 10 hours 50 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 12 hours 50 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 16 hours 25 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/03/2025 at 12:15, 10 minutes ago Baisha’s San Yue San Festival: International Students Immersed in Vibrant Ethnic Culture
Published on 04/03/2025 at 12:00, 25 minutes ago Linde Announces First Quarter 2025 Earnings and Conference Call Schedule
Published on 04/03/2025 at 11:42, 42 minutes ago Resolutions of the 2025 annual general meeting of Ørsted A/S
Published on 04/03/2025 at 09:00, 3 hours 24 minutes ago Partners Group to invest in Gestcompost, the largest organic waste manager in Spain, through a continuation fund
Published on 04/03/2025 at 09:45, 2 hours 39 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 31/03/2025
Published on 04/03/2025 at 09:35, 2 hours 49 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2025
Published on 04/03/2025 at 08:45, 3 hours 40 minutes ago Baikowski: Strong growth in 2024 full-year results
Published on 04/03/2025 at 08:00, 4 hours 25 minutes ago Availability of preparatory documents for the Annual Shareholders’ Meeting of OPmobility SE
Published on 04/03/2025 at 00:37, 11 hours 47 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code